The rise of GLP-1 weight loss medications has sparked an interesting phenomenon, one that has plastic surgeons on Long Island buzzing. These medications, such as Ozempic, Wegovy, and Zepbound, have become a popular tool in the fight against obesity, but their rapid weight loss effects have led to an unexpected side effect: excess skin.
Jeanne Erland's journey is a prime example. After losing an impressive 164 pounds with the help of these medications and a dedicated lifestyle change, she faced a new challenge - loose skin that hindered her progress and confidence. This is a common issue, and it's one that has driven many to seek plastic surgery solutions.
The Plastic Surgery Boom
Plastic surgeons on Long Island are reporting a surge in patients who, like Jeanne, have turned to surgery to address the excess skin resulting from their weight loss journey. The most talked-about side effect is the so-called "Ozempic face", a gaunt appearance that can occur with rapid weight loss. However, the issue extends beyond the face, affecting areas like the abdomen, breasts, thighs, and arms.
What's particularly interesting is the motivation behind these procedures. While some patients seek surgery purely for aesthetic reasons, others are driven by medical necessity. In fact, a report by the American Society of Plastic Surgeons reveals that 20% of individuals taking GLP-1 medications for weight loss have undergone plastic surgery, with a further 39% considering it.
The Impact of Excess Skin
Dr. Kevin Kresofsky, a plastic surgeon, describes the skin's inability to "recoil and tighten" after significant weight loss, comparing it to a deflated balloon. This loss of elasticity not only affects one's appearance but also has functional implications. For instance, the excess skin on the belly can lead to irritation, rashes, and even back and shoulder pain.
Additionally, the rapid weight loss associated with GLP-1 medications can result in muscle wasting and a loss of core strength, further impacting one's physical well-being.
The Role of GLP-1 Drugs
GLP-1 drugs, or Glucagon-like peptide-1 receptor agonists, were initially developed to treat diabetes. However, their ability to slow digestion and promote a feeling of fullness has made them a game-changer in the obesity treatment landscape. Since their specific approval for weight loss in 2021, these medications have gained popularity, with one in eight adults reporting their use for weight loss or chronic condition management, according to a 2025 KFF poll.
Addressing the Skin Issues
Plastic surgeons like Dr. David Pincus report seeing a wide range of skin issues in patients on GLP-1 medications, from the face down to the knees. For those with sagging breasts, the result can be neck and back pain, often requiring a breast lift or augmentation. Dr. Kresofsky emphasizes that body contouring surgery after massive weight loss is often considered reconstructive rather than cosmetic, and may be covered by insurance if deemed medically necessary.
The Importance of Lifestyle Changes
While GLP-1 medications can be a powerful tool, experts emphasize the importance of lifestyle modifications. Dr. David Pechman, director of bariatric surgery at South Shore University Hospital, highlights the need for resistance training and good protein intake to maximize elasticity and maintain muscle content. Healthy bones and muscle, as described by Dr. Pincus, act as a "scaffold" for the skin, and without lifestyle changes, the benefits of GLP-1s may be limited.
Conclusion
The rise of GLP-1 weight loss medications has undoubtedly transformed the obesity treatment landscape. However, as we've seen with Jeanne's story and the experiences of many others, it's crucial to consider the potential side effects and the holistic approach to weight loss and maintenance. While these medications can be a powerful tool, they should be used in conjunction with a healthy lifestyle to ensure long-term success and avoid the challenges of excess skin.
